Cargando…

Epidemiological Overview of Hodgkin Lymphoma across the Mediterranean Basin

The epidemiology of Hodgkin lymphoma (HL) has always been a source of fascination to researchers due to its heterogeneous characteristics of presentation. HL is an uncommon neoplasm of B-cell origin with an incidence that varies significantly by age, sex, ethnicity, geographic location and socioecon...

Descripción completa

Detalles Bibliográficos
Autores principales: Salati, Massimiliano, Cesaretti, Marina, Macchia, Matteo, Mistiri, Mufid El, Federico, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Università Cattolica del Sacro Cuore 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4103499/
https://www.ncbi.nlm.nih.gov/pubmed/25045456
http://dx.doi.org/10.4084/MJHID.2014.048
_version_ 1782327156426145792
author Salati, Massimiliano
Cesaretti, Marina
Macchia, Matteo
Mistiri, Mufid El
Federico, Massimo
author_facet Salati, Massimiliano
Cesaretti, Marina
Macchia, Matteo
Mistiri, Mufid El
Federico, Massimo
author_sort Salati, Massimiliano
collection PubMed
description The epidemiology of Hodgkin lymphoma (HL) has always been a source of fascination to researchers due to its heterogeneous characteristics of presentation. HL is an uncommon neoplasm of B-cell origin with an incidence that varies significantly by age, sex, ethnicity, geographic location and socioeconomic status. This complex pattern was also found to be replicated among Mediterranean basin populations. HL incidence rates progressively decreased from industrialized European countries such as France (ASR=2.61) and Italy (ASR=2.39) to less developed nations such as Albania (ASR=1.34) and Bosnia Herzegovina (ASR=1.1). Regarding HL mortality we have found that countries with the lowest incidence rates show the highest number of deaths from this cancer and viceversa. Finally, a wide gap in terms of survival was showed across the Mediterranean basin with survival rates ranged from 82.3% and 85.1% among Italian men and women, to 53.3 % and 59.3% among Libyan men and women, respectively. Factors such as the degree of socio-economic development, the exposure to risk factors westernization-related, the availability of diagnostic practices along with different genetic susceptibilities to HL may explain its variation across Mediterranean countries. Furthermore, the lack of health resources decisively contribute to the poor prognosis recorded in less developed region. In the future, the introduction of appropriate and accessible treatment facilities along with an adequate number of clinical specialists in the treatment of HL and other cancers are warranted in order to improve the outcomes of affected patients and treat a largely curable type of cancer in disadvantaged regions.
format Online
Article
Text
id pubmed-4103499
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Università Cattolica del Sacro Cuore
record_format MEDLINE/PubMed
spelling pubmed-41034992014-07-18 Epidemiological Overview of Hodgkin Lymphoma across the Mediterranean Basin Salati, Massimiliano Cesaretti, Marina Macchia, Matteo Mistiri, Mufid El Federico, Massimo Mediterr J Hematol Infect Dis Review Article The epidemiology of Hodgkin lymphoma (HL) has always been a source of fascination to researchers due to its heterogeneous characteristics of presentation. HL is an uncommon neoplasm of B-cell origin with an incidence that varies significantly by age, sex, ethnicity, geographic location and socioeconomic status. This complex pattern was also found to be replicated among Mediterranean basin populations. HL incidence rates progressively decreased from industrialized European countries such as France (ASR=2.61) and Italy (ASR=2.39) to less developed nations such as Albania (ASR=1.34) and Bosnia Herzegovina (ASR=1.1). Regarding HL mortality we have found that countries with the lowest incidence rates show the highest number of deaths from this cancer and viceversa. Finally, a wide gap in terms of survival was showed across the Mediterranean basin with survival rates ranged from 82.3% and 85.1% among Italian men and women, to 53.3 % and 59.3% among Libyan men and women, respectively. Factors such as the degree of socio-economic development, the exposure to risk factors westernization-related, the availability of diagnostic practices along with different genetic susceptibilities to HL may explain its variation across Mediterranean countries. Furthermore, the lack of health resources decisively contribute to the poor prognosis recorded in less developed region. In the future, the introduction of appropriate and accessible treatment facilities along with an adequate number of clinical specialists in the treatment of HL and other cancers are warranted in order to improve the outcomes of affected patients and treat a largely curable type of cancer in disadvantaged regions. Università Cattolica del Sacro Cuore 2014-07-01 /pmc/articles/PMC4103499/ /pubmed/25045456 http://dx.doi.org/10.4084/MJHID.2014.048 Text en This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Salati, Massimiliano
Cesaretti, Marina
Macchia, Matteo
Mistiri, Mufid El
Federico, Massimo
Epidemiological Overview of Hodgkin Lymphoma across the Mediterranean Basin
title Epidemiological Overview of Hodgkin Lymphoma across the Mediterranean Basin
title_full Epidemiological Overview of Hodgkin Lymphoma across the Mediterranean Basin
title_fullStr Epidemiological Overview of Hodgkin Lymphoma across the Mediterranean Basin
title_full_unstemmed Epidemiological Overview of Hodgkin Lymphoma across the Mediterranean Basin
title_short Epidemiological Overview of Hodgkin Lymphoma across the Mediterranean Basin
title_sort epidemiological overview of hodgkin lymphoma across the mediterranean basin
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4103499/
https://www.ncbi.nlm.nih.gov/pubmed/25045456
http://dx.doi.org/10.4084/MJHID.2014.048
work_keys_str_mv AT salatimassimiliano epidemiologicaloverviewofhodgkinlymphomaacrossthemediterraneanbasin
AT cesarettimarina epidemiologicaloverviewofhodgkinlymphomaacrossthemediterraneanbasin
AT macchiamatteo epidemiologicaloverviewofhodgkinlymphomaacrossthemediterraneanbasin
AT mistirimufidel epidemiologicaloverviewofhodgkinlymphomaacrossthemediterraneanbasin
AT federicomassimo epidemiologicaloverviewofhodgkinlymphomaacrossthemediterraneanbasin